| Datum |
Zeit |
Quelle |
Überschrift |
|---|
| 23.4.2024 | 13:25 | IHMARKETNEWS | Apple Loses Market Share in China, GM Surges in Pre-Market.. |
| 15.4.2024 | 20:00 | PRNUS | New Novartis Fabhalta® (iptacopan) data show clinically.. |
| 11.4.2024 | 13:00 | GLOBE | Arvinas Enters into a Transaction with Novartis, including a.. |
| 10.4.2024 | 13:13 | IHMARKETNEWS | Delta Generates US$37 Million Profit in Q1, Google and Intel.. |
| 06.4.2024 | 22:16 | PRNUS | New Novartis data show early addition of twice-yearly*.. |
| 15.2.2024 | 22:15 | EDGAR2 | Form S-8 POS - Securities to be offered to employees in.. |
| 06.2.2024 | 22:52 | EDGAR2 | Form SC TO-C - Written communication relating to an issuer.. |
| 06.2.2024 | 12:14 | IHMARKETNEWS | Boeing Faces Strike Threat, Palantir Up 18% After Recording.. |
| 05.2.2024 | 23:06 | EDGAR2 | Form SC TO-C - Written communication relating to an issuer.. |
| 02.2.2024 | 20:18 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 31.1.2024 | 13:44 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 31.1.2024 | 13:43 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 31.1.2024 | 13:42 | EDGAR2 | Form IRANNOTICE - Notice of disclosure filed pursuant to.. |
| 31.1.2024 | 13:38 | EDGAR2 | Form 20-F - Annual and transition report of foreign private.. |
| 31.1.2024 | 12:28 | IHMARKETNEWS | Walmart’s Stock Split, Elon Musk’s Billion-Dollar Package.. |
| 22.1.2024 | 07:59 | DJN | Sandoz to Acquire Cimerli Business from Coherus for $170.. |
| 12.1.2024 | 12:10 | IHMARKETNEWS | Wall Street Highlights: DocuSign Acquisition Battle, Tesla.. |
| 11.1.2024 | 19:02 | DJN | Cytokinetics Shares Slide as Novartis Reportedly Shies Away.. |
| 08.1.2024 | 19:43 | DJN | Cytokinetics Shares Jump 16% After WSJ Report of Novartis.. |
| 08.1.2024 | 16:41 | DJN | Novartis on Track for Record High Close -- Data Talk |
| 08.1.2024 | 12:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 08.1.2024 | 08:01 | DJN | Novartis's Scemblix Drug Meets Main Goals in Late-Stage.. |
| 05.1.2024 | 16:15 | DJN | Novartis to Make Pluvicto Radioligand Therapy at.. |
| 02.1.2024 | 13:46 | DJN | Voyager Therapeutics Shares Leap Premarket on Novartis.. |
| 11.12.2023 | 12:05 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 11.12.2023 | 08:02 | DJN | Novartis Drug Meets Primary Goal in Late-Stage Study for.. |
| 11.12.2023 | 01:39 | PRNUS | Novartis presents new 48-week results from Phase III.. |
| 06.12.2023 | 11:14 | DJN | Merck Shares Slump After Multiple Sclerosis Drug Fails in.. |
| 06.12.2023 | 06:18 | PRNUS | Novartis receives FDA approval for Fabhalta® (iptacopan),.. |
| 05.12.2023 | 12:25 | IHMARKETNEWS | Moody’s Reassesses China, GitLab Exceeds Estimates, Twilio.. |
| 29.11.2023 | 12:18 | IHMARKETNEWS | Amazon Unveils Innovative Services, Okta Discloses Data.. |
| 28.11.2023 | 21:08 | DJN | FDA Looking Into All Approved CAR T Therapies on Risk of.. |
| 28.11.2023 | 12:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 28.11.2023 | 08:12 | DJN | Novartis Raises Mid-Term Sales Growth Targets |
| 13.11.2023 | 15:16 | DJN | Legend Biotech Subsidiary in License Agreement With Novartis |
| 01.11.2023 | 13:45 | IHNW | Get Ready for Next Generation of Diabetes, Weight-Management.. |
| 01.11.2023 | 07:43 | DJN | Novartis Skin Treatment Drug Cosentyx Gets US FDA Approval |
| 30.10.2023 | 11:05 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 30.10.2023 | 08:07 | DJN | Novartis to Seek US Accelerated Approval of Atrasentan After.. |
| 27.10.2023 | 07:45 | DJN | Novartis Says FDA Deems Pluvicto Shortage Resolved, Supply.. |
| 24.10.2023 | 13:22 | IHMARKETNEWS | Tuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,.. |
| 24.10.2023 | 12:33 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 24.10.2023 | 09:32 | DJN | Novartis Raises Earnings Guidance Again After Key Drugs.. |
| 24.10.2023 | 07:48 | DJN | Novartis Raises Earnings Guidance After Key Drugs Boost.. |
| 06.10.2023 | 23:11 | DJN | Novartis Gets FDA Approval IV Formulation of Cosentyx |
| 04.10.2023 | 12:57 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 04.10.2023 | 11:17 | DJN | Novartis Spinoff Sandoz Group Valued at $11.2 Billion in.. |
| 02.10.2023 | 12:05 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 02.10.2023 | 08:10 | DJN | Novartis Says Kidney Drug Phase 3 Trial Reaches Positive.. |
| 26.9.2023 | 08:03 | DJN | Novartis's Sandoz to Commercialize Multiple Sclerosis.. |
Hot Features
Premium
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
